AMGA says transition to value-based care slowing

Capitol Hill
“The transition to risk-based arrangements is slowing, and there are very real obstacles in the way,” said Donald W. Fisher, AMGA’s president and CEO.

While healthcare continues to move toward value-based care, that transition has slowed, and physicians still need help from insurers and policymakers to succeed under new payment models.

Based on a survey of its members that shows a slow-down in the value-based care transition, the American Medical Group Association (AMGA) said in a press conference that Thursday it will make recommendations to the incoming Trump administration and Congress to remove impediments that limit access to claims data, risk-based insurance contracts and investment capital.

Congress should require federal and commercial insurance companies and providers to standardize data submission and reporting processes, as well as to provide access to all administrative claims data to healthcare providers, according to the trade association.

Webinar This Week

Curating a Higher Level of Personalized Care: Digital Health + Mom

A long-term digital health strategy is needed to respond to the technology demands of the modern patient while thriving as an independent hospital in a fiercely competitive market. In this webinar, Overlake and one of its digital health partners, Wildflower Health, will discuss how Overlake has approached digital health and why it chose to focus early efforts on expectant moms within its patient population.

A 2016 survey by the AMGA found that fee-for-service payments to multispecialty groups and integrated delivery systems continued to decline by more than 20%, with value-based payments increasing proportionately, according to a report (PDF) from the trade association. The report can be downloaded free from the association website.

However, while a majority of the 115 respondents are ready to accept downside risk within two years, they also reported that commercial payers generally are not offering risk products in their markets.

“The transition to risk-based arrangements is slowing, and there are very real obstacles in the way,” Donald W. Fisher, AMGA’s president and CEO, said during the press conference.

The report indicated that impediments to taking risk identified by AMGA members last year—including data-sharing issues and the lack of commercial risk products—have largely not been addressed. Here are some of the obstacles the report identifies:

For instance, in Montana there are no commercial risk products currently available, Heidi Duncan, M.D., the physician director of health policy at Billings Clinic, said during the press conference. Another problem is that healthcare organizations need complete and accurate real-time data in order to manage the health of patients, she said.

The report comes as physician practices begin to transition to the new Medicare payment system to implement the Medicare Access and CHIP Reauthorization Act, with the goal of the Department of Health and Human Services tying 90% of Medicare payments to “value” by 2018.

Private payers have not moved as quickly, and the AMGA said it will recommend steps to Congress to keep the transition to value-based care moving ahead. The group recommends Congress create a fund that allows providers to use income on a tax-free basis to invest in taking downside risk and allow access to capital.

It also recommends steps to help physicians succeed under MACRA’s Alternative Payment Models (APMs), including not penalizing Advanced APMs if there are insufficient risk products in their local markets, allowing Medicare Advantage revenue to count in performance year 2019 toward meeting the Advanced APM revenue thresholds, and allowing Track 1 ACOs to be eligible as Advanced APMs.

The AMGA's 2015 survey noted that if policymakers did not address obstacles, the transition to value-based payment systems would slow. “According to this year’s data, that deceleration is already occurring. Congress and HHS need to address these impediments soon, or the transition to value will either be unnecessarily difficult and prolonged, or it may grind to a halt much like it did in the 1990s,” the AMGA's new report concluded.

Suggested Articles

Walmart has delayed a new policy originally set to begin January 1 that would have required electronic prescriptions for controlled substances.

Blue Cross Blue Shield of Michigan announced that it has joined up with seven providers in the state to launch “Blueprint for Affordability."

Healthcare system leaders and individuals need to look inward to tackle social determinants of health, Donald Berwick said.